Clinical Trial Update: Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder [NA]

View source ↗

Summary

Pfizer-sponsored clinical trial assessing a new scale to measure onset of action in generalized anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Snippet

Sponsor: Pfizer | Conditions: Anxiety Disorders | NA | Status: COMPLETED